| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.05M | - | |
| Other | 52.8K | $8.66M | - | |
| Other | 46.8K | $7.68M | - | |
| Other | 39.6K | $6.51M | -36,937 | |
| Other | 36.8K | $6.05M | -11,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2018 | Benevich Eric62 | Chief Commercial Officer | Sell | 820 | $83.14 | $68,174.23 | -24.1% | |
| Jan 24, 2018 | Rastetter William H48 | Director | Sale+OE | 9,500 | $90.00 | $855,000.00 | -27.7% | |
| Jan 16, 2018 | Obrien Christopher Flint | Chief Medical Officer | Sell | 1,750 | $79.14 | $138,499.03 | -3.3% | |
| Jan 16, 2018 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,625 | $79.12 | $128,563.01 | -2.0% | |
| Jan 16, 2018 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 3,750 | $78.89 | $295,819.88 | -1.1% | |
| Jan 16, 2018 | Gano Kyle54 | Chief Business Development Off | Sell | 1,625 | $79.05 | $128,459.50 | -2.1% | |
| Jan 16, 2018 | Bozigian Haig P. | Chief Development Officer | Sell | 1,625 | $79.12 | $128,574.71 | -1.2% | |
| Jan 3, 2018 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 1,979 | $79.36 | $157,053.44 | -13.1% | |
| Jan 2, 2018 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sale+OE | 18,084 | $77.52 | $1,401,822.85 | -58.1% | |
| Dec 28, 2017 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 15,237 | $75.00 | $1,142,775.00 | -53.7% |